Zimmer Biomet Holdings Inc (ZBH)

Operating profit margin

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Operating income (ttm)	US$ in thousands	1,277,700	895,200	873,900	825,200	696,300	858,400	856,100	800,000	860,300	1,138,100	1,194,300	797,800	83,100	8,300	-45,100	331,300	1,137,500	10,200	-12,300	79,000
Revenue (ttm)	US$ in thousands	7,171,500	7,054,100	6,993,800	6,933,800	6,780,400	6,827,800	7,061,000	7,290,300	7,452,200	7,716,200	7,722,600	6,923,200	6,840,900	6,881,300	6,840,200	7,596,700	7,805,400	7,750,700	7,677,500	7,646,100
Operating profit margin		17.82%	12.69%	12.50%	11.90%	10.27%	12.57%	12.12%	10.97%	11.54%	14.75%	15.46%	11.52%	1.21%	0.12%	-0.66%	4.36%	14.57%	0.13%	-0.16%	1.03%

December 31, 2023 calculation

Operating profit margin = Operating income (ttm) ÷ Revenue (ttm)
= $1,277,700K ÷ $7,171,500K
= 17.82%

Zimmer Biomet Holdings Inc's operating profit margin has been showing a positive trend over the past quarters. The operating profit margin improved from 12.75% in Q1 2022 to 19.63% in Q4 2023. This indicates that the company has been able to effectively control its operating expenses and generate more profit from its operations.

The consistent increase in operating profit margin reflects improved efficiency and effectiveness in managing costs and optimizing revenue streams. This trend is a positive indicator of the company's operational performance and financial health.

Overall, the upward trajectory of Zimmer Biomet's operating profit margin demonstrates the company's ability to enhance profitability and create value for its shareholders. It suggests that the company's business strategies and operational efficiency initiatives are yielding favorable results.